Why the study?
Do ACE inhibitors improve regional myocardial blood flow and reduce ischemic injury during coronary artery occlusion in dogs?
Do ACE inhibitors improve regional myocardial blood flow and reduce ischemic injury during coronary artery occlusion in dogs?
In a canine model of coronary occlusion, ACE inhibitors did not improve regional myocardial blood flow or protect against ischemic injury despite reducing systemic blood pressure.
Answers are grounded in this paper and cite their sources.
No acute ischemic protection from ACE inhibitors in this canine model; leaves open human translation and requires further study.
The effects of 4 angiotensin I converting enzyme inhibitors (ACEI), captopril, enalapril, ramipril, and trandolapril, were investigated on regional myocardial blood flow (RMBF, radioactive microspheres) distribution in ischemic and nonischemic zones and on ST-segment elevation in ischemic zones during intermittent coronary artery occlusion in anesthetized dogs. The 4 ACEI inhibited plasma ACE activity to an almost similar extent. All similarly reduced systemic blood pressure, an effect related to a decrease in systemic vascular resistance. Heart rate and myocardial contractility were not affected, but myocardial oxygen consumption presumably decreased because of the reduction in afterload. RMBF and their distribution (between epicardial and endocardial layers and between nonischemic and ischemic zones) were not modified by ACEI. Coronary vascular resistance was slightly decreased in nonischemic zones. ACEI had no effect on ST-segment elevation in ischemic zones. Thus, in this experimental model, all ACEI exhibited the same profile, including no change in RMBF and affording no protection against ischemic injury.
No takes yet. Share an insight, caveat, or question.
Berdeaux et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: